137 related articles for article (PubMed ID: 20164548)
1. IkappaBalpha promoter polymorphisms in patients with Behçet's disease.
Hung YH; Wu CC; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
Dis Markers; 2010; 28(1):55-62. PubMed ID: 20164548
[TBL] [Abstract][Full Text] [Related]
2. IkBα promoter polymorphisms in patients with ankylosing spondylitis.
Hung YH; Ou TT; Lin CH; Li RN; Lin YC; Tsai WC; Liu HW; Yen JH
Rheumatol Int; 2009 Nov; 30(1):93-7. PubMed ID: 19363678
[TBL] [Abstract][Full Text] [Related]
3. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
[TBL] [Abstract][Full Text] [Related]
4. I kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus.
Lin CH; Wang SC; Ou TT; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 May; 28(3):207-13. PubMed ID: 18071880
[TBL] [Abstract][Full Text] [Related]
5. Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Balood M; Mesbah-Namin SA; Sanati MH; Zahednasab H; Sahraian MA; Ataei M
Mol Biol Rep; 2014 Feb; 41(2):613-6. PubMed ID: 24368589
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians.
Zhai R; Zhou W; Gong MN; Thompson BT; Su L; Yu C; Kraft P; Christiani DC
Crit Care Med; 2007 Mar; 35(3):893-8. PubMed ID: 17235259
[TBL] [Abstract][Full Text] [Related]
7. Inhibitor IkappaBalpha promoter functional polymorphisms in patients with rheumatoid arthritis.
Li RN; Hung YH; Lin CH; Chen YH; Yen JH
J Clin Immunol; 2010 Sep; 30(5):676-80. PubMed ID: 20563630
[TBL] [Abstract][Full Text] [Related]
8. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C.
He Y; Zhang H; Yin J; Xie J; Tan X; Liu S; Zhang Q; Li C; Zhao J; Wang H; Cao G
Carcinogenesis; 2009 Nov; 30(11):1916-22. PubMed ID: 19797428
[TBL] [Abstract][Full Text] [Related]
9. IL-18 gene polymorphisms in aphthous stomatitis vs. Behçet's disease in a cohort of Egyptian patients.
Hazzaa HH; Rashwan WA; Attia EA
J Oral Pathol Med; 2014 Nov; 43(10):746-53. PubMed ID: 24935632
[TBL] [Abstract][Full Text] [Related]
10. IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis.
Lin CH; Ou TT; Wu CC; Tsai WC; Liu HW; Yen JH
Int J Immunogenet; 2007 Feb; 34(1):51-4. PubMed ID: 17284228
[TBL] [Abstract][Full Text] [Related]
11. Association of NFKB1 and NFKBIA polymorphisms in relation to susceptibility of Behçet's disease.
Yenmis G; Oner T; Cam C; Koc A; Kucuk OS; Yakicier MC; Dizman D; Kanigur Sultuybek G
Scand J Immunol; 2015 Jan; 81(1):81-6. PubMed ID: 25367031
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease.
Kamoun M; Chelbi H; Houman MH; Lacheb J; Hamzaoui K
Hum Immunol; 2007 Mar; 68(3):201-5. PubMed ID: 17349875
[TBL] [Abstract][Full Text] [Related]
13. Associations of IL-17 and IL-17 receptor polymorphisms with Behçet's disease in Denizli Province of Turkey.
Arıkan S; Öztürk O; Duygulu Ş; Atalay EÖ; Atalay A
Immunol Res; 2023 Aug; 71(4):600-608. PubMed ID: 36701075
[TBL] [Abstract][Full Text] [Related]
14. No association of PTPN22 polymorphisms with susceptibility to ocular Behcet's disease in two Chinese Han populations.
Zhang Q; Hou S; Jiang Z; Du L; Li F; Xiao X; Kijlstra A; Yang P
PLoS One; 2012; 7(3):e31230. PubMed ID: 22396730
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of Promoter Region of TNF-α Gene in Iranian Azeri Turkish Patients with Behçet's Disease.
Abdolmohammadi R; Bonyadi M
J Korean Med Sci; 2017 Jan; 32(1):33-37. PubMed ID: 27914129
[TBL] [Abstract][Full Text] [Related]
16. A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet's disease.
Sawalha AH; Hughes T; Nadig A; Yılmaz V; Aksu K; Keser G; Cefle A; Yazıcı A; Ergen A; Alarcón-Riquelme ME; Salvarani C; Casali B; Direskeneli H; Saruhan-Direskeneli G
Arthritis Rheum; 2011 Nov; 63(11):3607-12. PubMed ID: 21918955
[TBL] [Abstract][Full Text] [Related]
17. Association of MMP-9 gene polymorphisms with Behçet's disease risk.
Naouali A; Kaabachi W; Tizaoui K; Amor AB; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Mar; 164(1):18-24. PubMed ID: 25639450
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin Associated and SH3 Domain Containing B (UBASH3B) Gene Association with Behcet's Disease in Iranian Population.
Shahriyari E; Bonyadi M; Jabbarpoor Bonyadi MH; Soheilian M; Yaseri M; Ebrahimiadib N
Curr Eye Res; 2019 Feb; 44(2):200-205. PubMed ID: 30289285
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the NOS3 gene in Tunisian patients with Behçet's disease.
Kallel A; Sbaï MH; Houman MH; Sediri Y; Ouertani D; Smiti Khanfir M; Ben Ghorbel I; Jemaa R; Kaabachi N
Int J Immunogenet; 2015 Apr; 42(2):87-92. PubMed ID: 25639851
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.
Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
